Disease | The given name of EMVs | EMVs’ derivation | EMVs’ target | Involved miRNAs | Research content | References |
---|---|---|---|---|---|---|
Ex vivo | Exosome | MC/9 cells | HMC-1 cells MC/9 cells | N/A | Mediating intercellular communication | [26] |
Atherosclerosis | MV | THP-1 cells | HMEC-1 | miR-150 | Enhancing migration | [34] |
Inflammation | Exosome | Tregs | Th1 cells | Let-7d | Preventing inflammation | [37] |
Kidney ischemia-reperfusion injury | MV | EPCs | Hypoxic resident renal cells | miR-126 miR-296 | Protecting resident kidney | [46] |
Hindlimb ischemia | MV | EPCs | Endothelial cells | miR-126 miR-296 | Pro-neovascularization | [48] |
Breast cancer | MV | Macrophages | Cancer cells | miR-223 | Promoting invasion | [59] |
Gastric cancer | Exosome | AZ-P7a cells | Microenvironment | Let-7 | Pro-oncogenesis | [89] |
Leukemia | Exosome | K562 cells | HUVECs | miR-17-92 | Enhancing migration and tube formation | [90] |
MM | Exosome | BMSC | MM cells | miR-15 | Facilitating progression | [92] |
Glioblastoma multiforme | MV | Serum | Circulating | N/A | Diagnostic marker | [29] |
PC | Exosome | PC-3 | Conditioned media | N/S | Mediating intercellular communication | [63] |
Melanoma | Exosome | Serum | Circulation | miR-125b | Monitor indicator | [67] |
HCC | Nano vesicle | Hep3B HepG2 PLC/PRF/5 Cells | Hep3B HepG2 PLC/PRF/5 cells | miR-16 | Mediating intercellular communication | [68] |
Ovarian cancer | Exosome | Serum | Circulation | N/S | Diagnostic marker | [71] |
Breast cancer | Exosome | Serum | Circulation | miR-21 | Monitor indicator | [73] |
Lung cancer | Exosome | Serum | Circulation | N/S | Diagnostic marker | [74] |
NSCLC | Exosome | Serum | Circulation | miR-21 miR-155 | Diagnostic marker | [75] |